The trading halt concerns the release of 1200 mg trial data from DARRT-1. My guess is that the trading halt was designed to prevent anyone with price-sensitive information taking advantage of existing shareholders by buying their shares at low prices.
We have seen this before, particularly if conference organisers demand that price-sensitive data be released exclusively to their meeting. A massive spike in price and volume recently occurred in the US when good trial results were described in a poster that could be found online, before presentation. While some might applaud those who took advantage of their information, I feel sorry for the shareholders who sold, not knowing the full story.
The release of 1200 mg DARRT data is a significant milestone for Noxopharm. The Trading Halt suggests that the data will indeed be price-sensitive. Bring it on!
- Forums
- ASX - By Stock
- Trading Halt
The trading halt concerns the release of 1200 mg trial data from...
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
6.6¢ |
Change
-0.004(5.71%) |
Mkt cap ! $19.28M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 6.6¢ | $3.396K | 49.28K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 57227 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 11999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 57227 | 0.066 |
2 | 22703 | 0.065 |
2 | 32786 | 0.061 |
4 | 105033 | 0.060 |
3 | 136932 | 0.059 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 11999 | 1 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 75689 | 4 |
Last trade - 10.52am 05/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |